KRAS and neoplasm: In the present study we have compared the DNA sequence mutation status of the genes KRAS, BRAF, PIK3CA, PTEN, and TP53 in tumor samples from patients younger than 50 years at diagnosis and without known hereditary syndromes, and stratified according to MSI status and elderly CRC patients.